Hiroaki Serizawa
Plus aucun poste en cours
Profil
Dr. Hiroaki Serizawa is a Chief Executive Officer at AMD Therapeutics LLC.
Dr. Serizawa was previously employed as a President, Chief Executive Officer & Director by Coyote Pharmaceuticals, Inc., an Executive Director by Lifescience Catalyst Partners, Inc., an Assistant Professor by University of Kansas, a Principal by TNP Partners Corp., and a Chief Executive Officer by Tor USA, Inc.
Postes actifs de Hiroaki Serizawa
| Sociétés | Poste | Début |
|---|
Anciens postes connus de Hiroaki Serizawa
| Sociétés | Poste | Fin |
|---|---|---|
| Lifescience Catalyst Partners, Inc. | Directeur/Membre du Conseil | 01/01/2005 |
| University of Kansas | Corporate Officer/Principal | 01/01/2003 |
TNP Partners Corp.
 TNP Partners Corp. Investment ManagersFinance TNP Partners Corp (TNP) is an independent partner-owned firm located near Tokyo with a U.S. office in Sunnyvale, California. Formerly known as TSUNAMI Network Partners Corp., TNP was established in 2000 by government and private entities in Kanagawa on the west side of Tokyo. The firm seeks to attract venture companies as well as business support resources to the Kanagawa area and foster a Silicon Valley-like business community. They operate in close relationship with their asset management subsidiary TNP On The Road Corp., managing venture capital investment funds. | Corporate Officer/Principal | - |
| Tor USA, Inc. | Directeur Général | - |
Coyote Pharmaceuticals, Inc.
 Coyote Pharmaceuticals, Inc. BiotechnologyHealth Technology Coyote Pharmaceuticals, Inc. operates a biopharmaceutical company. It focuses on creating high value therapeutics for large unmet medical needs in several therapeutic categories including neurodegenerative, cardiovascular, oncologic, and inflammatory diseases. The company was founded by Hiroaki Serizawa in 2009 and is headquartered in Menlo Park, CA. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Coyote Pharmaceuticals, Inc.
Coyote Pharmaceuticals, Inc. BiotechnologyHealth Technology Coyote Pharmaceuticals, Inc. operates a biopharmaceutical company. It focuses on creating high value therapeutics for large unmet medical needs in several therapeutic categories including neurodegenerative, cardiovascular, oncologic, and inflammatory diseases. The company was founded by Hiroaki Serizawa in 2009 and is headquartered in Menlo Park, CA. | Health Technology |
TNP Partners Corp.
TNP Partners Corp. Investment ManagersFinance TNP Partners Corp (TNP) is an independent partner-owned firm located near Tokyo with a U.S. office in Sunnyvale, California. Formerly known as TSUNAMI Network Partners Corp., TNP was established in 2000 by government and private entities in Kanagawa on the west side of Tokyo. The firm seeks to attract venture companies as well as business support resources to the Kanagawa area and foster a Silicon Valley-like business community. They operate in close relationship with their asset management subsidiary TNP On The Road Corp., managing venture capital investment funds. | Finance |
| Tor USA, Inc. | |
| Lifescience Catalyst Partners, Inc. |
